{"entity":{"type":"insider","cik":"0001721017","url":"/insider/0001721017","json_url":"/insider/0001721017.json","name":"Goyal Vikas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2017-11-07","last":"2021-03-08","span_basis":"filed_date"},"name_variants":[{"name":"Goyal Vikas","source":"filing","n_filings":4,"first_seen":"2017-11-07","last_seen":"2021-03-08"}],"transactions":[{"id":4660661,"accession":"0001209191-21-018758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-018758","line_url":"/filing/0001209191-21-018758#line-1","is_derivative":false,"issuer_cik":"0001679363","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001679363","owner_cik":"0001721017","owner_name":"Goyal Vikas","owner_display_name":"Goyal Vikas","owner_url":"/insider/0001721017","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":70000.0,"total_display":"70,000.00","total_whole":"70,000","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-08","scope":"insider"},{"id":2328976,"accession":"0000899243-20-019873","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-019873","line_url":"/filing/0000899243-20-019873#line-2","is_derivative":false,"issuer_cik":"0001721017","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001721017","owner_cik":"0001721017","owner_name":"Goyal Vikas","owner_display_name":"Goyal Vikas","owner_url":"/insider/0001721017","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1450.0,"shares_display":"1,450","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":26100.0,"total_display":"26,100.00","total_whole":"26,100","shares_owned_after":87764.0,"shares_owned_after_display":"87,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider"},{"id":7786680,"accession":"0001179110-19-008261","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-19-008261","line_url":"/filing/0001179110-19-008261#line-3","is_derivative":false,"issuer_cik":"0001679363","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001679363","owner_cik":"0001721017","owner_name":"Goyal Vikas","owner_display_name":"Goyal Vikas","owner_url":"/insider/0001721017","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":2633772.0,"shares_owned_after_display":"2,633,772","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-01","scope":"insider"},{"id":4256834,"accession":"0000899243-17-025508","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-17-025508","line_url":"/filing/0000899243-17-025508#line-5","is_derivative":false,"issuer_cik":"0001701108","issuer_name":"Spero Therapeutics, Inc.","issuer_ticker":"SPRO","issuer_name_source":null,"issuer_url":"/issuer/0001701108","owner_cik":"0001721017","owner_name":"Goyal Vikas","owner_display_name":"Goyal Vikas","owner_url":"/insider/0001721017","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":428571.0,"shares_display":"428,571","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":1854006.0,"shares_owned_after_display":"1,854,006","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-06","filed_date":"2017-11-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001679363","name":"Morphic Holding, Inc.","url":"/issuer/0001679363","role":"Director","n_filings":2,"first_seen":"2019-07-01","last_seen":"2021-03-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001807901","name":"Pandion Therapeutics, Inc.","url":"/issuer/0001807901","role":"Officer","n_filings":1,"first_seen":"2020-07-21","last_seen":"2020-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001701108","name":"Spero Therapeutics, Inc.","url":"/issuer/0001701108","role":"Director","n_filings":1,"first_seen":"2017-11-07","last_seen":"2017-11-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001721017","retrieved_at":"2026-08-27T02:44:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}